Harvard Health Blog

Turning to drugs and treatments before they are “ready for prime time”

Posted September 21, 2015, 8:00 am Amy Ship, M.D., Contributing Editor Itís not a situation any of us would wish for. What if you had a terminal illness like cancer or ALS (Lou Gehrigís disease), or a rare, debilitating disease, and knew there was treatment that might help you, but was not yet approved by the FDA? Fortunately, there is a way to gain access to experimental treatments or drugs. Your doctor can request…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In